Complementary and alternative medicines and dietary interventions in multiple sclerosis: What is being used in South Australia and why?

Complementary Therapies in Medicine

Volumn 17, Issue 4, 2009, Pages 216-223

  Leong, E M ^a   Semple, S J ^a   Angley, M ^a   Siebert, W ^b   Petkov, J ^a   McKinnon, R A ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Australia; Complementary and alternative medicine; Dietary intervention; Frequency; Multiple sclerosis; Perceptions of efficacy; Reasons for use; Survey

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; CARNITINE; CEREBROSIDE; COD LIVER OIL; CRANBERRY EXTRACT; CYANOCOBALAMIN; FISH OIL; FOLIC ACID; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLUCOSAMINE; HOMEOPATHIC AGENT; HYPERICUM PERFORATUM EXTRACT; IRON; MAGNESIUM; MELATONIN; PRIMROSE OIL; PYRIDOXINE; RETINOL; RIBOFLAVIN; SELENIUM; THIAMINE; THIOCTIC ACID; UBIDECARENONE; UNINDEXED DRUG; VALERIAN; VITAMIN D; ZINC;

ACCESS TO INFORMATION; ADULT; ALTERNATIVE MEDICINE; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; EDUCATIONAL STATUS; FAMILY; FEMALE; FRIEND; GLUTEN FREE DIET; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PRACTITIONER; HEALTH STATUS; HUMAN; LOW CARBOHYDRATE DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MICTURITION DISORDER; MOBILIZATION; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; POSTAL MAIL; QUESTIONNAIRE; SYMPTOM; WELLBEING;

COMPLEMENTARY THERAPIES; EDUCATIONAL STATUS; FATTY ACIDS, ESSENTIAL; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MINERALS; MULTIPLE SCLEROSIS; NUTRITION THERAPY; PHYTOTHERAPY; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SOUTH AUSTRALIA; VITAMINS;

EID: 67650717635     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2009.03.001     Document Type: Article

References (34)

1. Pender M.P. Multiple sclerosis: early diagnosis and comprehensive management. Medicine Today 7 (2006) 14-21
2. Porth C. Essentials of pathophysiology: Concepts of altered health states. 2nd edn. (2007), Lippincott Williams & Wilkins, Philadelphia, PA
3. Flachenecker P. Epidemiology of neuroimmunological diseases. Journal of Neurology 253 Suppl. 5 (2006) V/2-V/8
4. Calabresi P.A. Diagnosis and management of multiple sclerosis. American Family Physician 70 (2004) 1935-1944
5. Apel A., Greim B., and Zettl U.K. How frequently do patients with multiple sclerosis use complementary and alternative medicine?. Complementary Therapies in Medicine 13 (2005) 258-263
6. Nayak S., Matheis R.J., Schoenberger N.E., and Shiflett S.C. Use of unconventional therapies by individuals with multiple sclerosis. Clinical Rehabilitation 17 (2003) 181-191
7. Pucci E., Cartechini E., Taus C., and Giuliani G. Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients. European Journal of Neurology 11 (2004) 263-267
8. Shinto L., Yadav V., Morris C., Lapidus J.A., Senders A., and Bourdette D. The perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosis. Complementary Therapies in Medicine 13 (2005) 264-272
9. Schwarz S., and Leweling H. Multiple sclerosis and nutrition. Multiple Sclerosis 11 (2005) 24-32
10. Berkman C.S., Pignotti M.G., Cavallo P.F., and Holland N.J. Use of alternative treatments by people with multiple sclerosis. Neurorehabilitation and Neural Repair 13 (1999) 243-254
11. Marrie R.A., Hadjimichael O., and Vollmer T. Predictors of alternative medicine use by multiple sclerosis patients. Multiple Sclerosis 9 (2003) 461-466
12. Sastre-Garriga J., Munteis E., Rio J., Pericot I., Tintore M., and Montalban X. Unconventional therapy in multiple sclerosis. Multiple Sclerosis 9 (2003) 320-322
13. Apel A., Greim B., Konig N., and Zettl U.K. Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis. Journal of Neurology 253 (2006) 1331-1336
14. Hooper K., Pender M., Webb P., and McCombe P. Use of traditional and complementary medical care by patients with multiple sclerosis in South-East Queensland. International Journal of MS Care 3 (2001) 3-13
15. Shinto L., Yadav V., Morris C., Lapidus J.A., Senders A., and Bourdette D. Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis. Multiple Sclerosis 12 (2006) 94-100
16. MacLennan A.H., Myers S.P., and Taylor A.W. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Medical Journal of Australia 184 (2006) 27-31
17. Stankiewicz M., Smith C., Alvino H., and Norman R. The use of complementary medicine and therapies by patients attending a reproductive medicine unit in South Australia: a prospective survey. Australian and New Zealand Journal of Obstetrics and Gynaecology 47 (2007) 145-149
18. Bowling A. Alternative medicine and multiple sclerosis (2001), Demos Medical Publishing, New York
19. Huntley A. A review of the evidence for efficacy of complementary and alternative medicines in MS. International MS Journal 13 4 (2006) 5-12
20. Yadav V., Shinto L., Morris C., Senders A., Baldauf-Wagner S., and Bourdette D. Use and self-reported benefit of complementary and alternative medicine among multiple sclerosis patients. International Journal of MS Care 8 (2006) 5-10
21. Farinotti M., Simi S., Di Pietrantonj C., et al. Dietary interventions for multiple sclerosis. Cochrane of Database Systematic Reviews 1 (2007) CD004192
22. Payne A. Nutrition and diet in the clinical management of multiple sclerosis. Journal of Human Nutrition & Dietetics 14 (2001) 349-357
23. Miller A., Korem M., Almog R., and Galboiz Y. Vitamin B12, demyelination, remyelination and repair in multiple sclerosis. Journal of Neurological Sciences 233 (2005) 93-97
24. Sandyk R., and Awerbuch G.I. Vitamin B12 and its relationship to age of onset of multiple sclerosis. International Journal of Neuroscience 71 (1993) 93-99
25. Goodkin D.E., Jacobsen D.W., Galvez N., Daughtry M., Secic M., and Green R. Serum cobalamin deficiency is uncommon in multiple sclerosis. Archives of Neurology 51 (1994) 1110-1114
26. Johnson S. The possible role of gradual accumulation of copper, cadmium, lead and iron and gradual depletion of zinc, magnesium, selenium, vitamins B2, B6, D, and E and essential fatty acids in multiple sclerosis. Medical Hypotheses 55 (2000) 239-241
27. Munger K.L., Zhang S.M., O'Reilly E., et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 62 (2004) 60-65
28. Weinstock-Guttman B., Baier M., Park Y., et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukotrienes % Essential Fatty Acids 73 (2005) 397-404
29. Bishop F.L., and Lewith G.T. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. eCAM (2008) 10.1093/ecam/nen023
30. Pugliatti M., Rosati G., Carton H., et al. The epidemiology of multiple sclerosis in Europe. European Journal of Neurology 13 (2006) 700-722
31. Barnett M.H., Williams D.B., Day S., Macaskill P., and McLeod J.G. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. Journal of the Neurological Sciences 213 (2003) 1-6
32. Access economics. Acting positively: strategic implications of the economic costs of multiple sclerosis in Australia. Canberra, ACT, MS Australia. ; 2005 [accessed 24.11.08].
33. McLeod J.G., Hammond S.R., and Hallpike J.F. Epidemiology of multiple sclerosis in Australia: with NSW and SA survey results. Medical Journal of Australia 160 (1994) 117-119 121
34. Vollmer T. The natural history of relapses in multiple sclerosis. Journal of the Neurological Sciences 256 Suppl. 1 (2007) S5-S13